Hinge Health Inc. (NYSE:HNGE - Free Report) - Research analysts at William Blair issued their Q2 2025 EPS estimates for shares of Hinge Health in a research note issued on Monday, June 16th. William Blair analyst R. Daniels anticipates that the company will post earnings per share of $0.06 for the quarter. William Blair currently has a "Outperform" rating on the stock. William Blair also issued estimates for Hinge Health's Q3 2025 earnings at $0.07 EPS, Q4 2025 earnings at $0.12 EPS, FY2025 earnings at $0.46 EPS, FY2026 earnings at $0.57 EPS and FY2027 earnings at $0.85 EPS.
A number of other brokerages have also recently weighed in on HNGE. Evercore ISI began coverage on Hinge Health in a research report on Monday. They set an "outperform" rating and a $50.00 price target on the stock. Piper Sandler initiated coverage on Hinge Health in a research report on Monday. They issued an "overweight" rating and a $41.00 target price on the stock. Raymond James Financial began coverage on shares of Hinge Health in a report on Monday. They set an "outperform" rating and a $45.00 price target for the company. Royal Bank Of Canada initiated coverage on shares of Hinge Health in a research report on Monday. They set an "outperform" rating and a $45.00 price target for the company. Finally, Wall Street Zen upgraded shares of Hinge Health to a "hold" rating in a research report on Monday, June 2nd. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $46.00.
View Our Latest Research Report on Hinge Health
Hinge Health Trading Up 4.7%
HNGE traded up $1.79 on Wednesday, hitting $39.79. 771,425 shares of the company's stock were exchanged, compared to its average volume of 1,192,915. Hinge Health has a twelve month low of $33.42 and a twelve month high of $43.80.
Hinge Health Company Profile
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Featured Stories

Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.